MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    Unraveling the Intertwined Relationship of DBS, Parkinson’s Disease Subtype and LEDD: A Retrospective Study

    T. Mehta, V. Lavu, C. Hess, A. Ramirez-Zamora, M. Okun, J. Wong (Gainesville, USA)

    Objective: To assess the impact of deep brain stimulation (DBS) target and Parkinson’s disease (PD) motor subtype on the total levodopa equivalent daily dose (LEDD)…
  • 2025 International Congress

    Therapeutic Potential of GLP-1 Receptor Agonists in Parkinson’s Disease: A Systematic Review and Meta-Analysis

    A. Badran, M. Gbreel (Cairo, Egypt)

    Objective: To assess the safety and effectiveness of GLP-1 RAs in patients with PD. Background: Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by…
  • 2025 International Congress

    Individual physiomarkers of levodopa-induced local field potential fluctuations interact with deep brain stimulation in Parkinson’s disease

    M. de Neeling, C. Oehrn, B. Keulen, M. Stam, D. Hubers, R. de Bie, P. Schuurman, B. van Wijk, A. Buijink, M. Beudel (Sacramento, USA)

    Objective: We investigated the behavior of LFPs in 57 patients across therapeutic states using a data-driven method to find personalized physiomarkers. Background: The power of…
  • 2025 International Congress

    Phase 1 and 1b Pharmacodynamic Data Support Central Modulation of Lysosomal Pathways With BIIB122/DNL151, a LRRK2 Kinase Inhibitor: Insights for the LUMA Trial

    K. Fraser, A. Lang, L. Kalia, R. Hauser, J. Greenamyre, Y. Moroishi, J. Kluss, B. Hersh, K. Ferber, R. Maciuca, C. Paián-Ruiz, R. Llorens-Arenas, D. Jennings, S. Huntswork-Rodriguez, D. Graham (Tampa, USA)

    Objective: Evaluate the effects of BIIB122/DNL151 treatment on CSF levels of pRab10, a biomarker of CNS LRRK2 modulation, in a Phase 1 study in healthy…
  • 2025 International Congress

    Identification of Rigidity in Parkinson’s Disease Using Wearable Technology

    P. Sharma, C. Sotirakis, J. Huxley, J. Fitzgerald, C. Antoniades (Oxford, United Kingdom)

    Objective: To evaluate the capacity of upper limb kinematic measures, collected using wearable technology, in (a) capturing clinical rigidity in Parkinson’s disease (PD) and (b)…
  • 2025 International Congress

    1H-NMR and UPLC/MS Metabolomics Identify Disrupted Homeostasis of Energy, Amino Acids, and Glutathione Metabolism as Serum Signatures in Parkinson’s Disease Patients

    A. Imarisio, J. Gervasoni, C. Marino, L. Santucci, E. Napolitano, T. Nuzzo, I. Yahyavi, M. Avenali, M. Cicchinelli, C. Galandra, M. Picascia, M. Grimaldi, C. Pacchetti, F. Errico, AM. D'Ursi, A. Urbani, A. Usiello, EM. Valente (Rome, Italy)

    Objective: We sought to identify a signature distinctive of Parkinson’s disease (PD) through two independent metabolomics approaches. Background: A recent meta-analysis showed a considerable inconsistency…
  • 2025 International Congress

    Interpretable voice-based detection of Parkinson’s disease using language-independent graph neural networks

    S. Patel, C. Antoniades, J. Fitzgerald, O. Bredemeyer (Oxford, United Kingdom)

    Objective: To develop a robust, interpretable, and language-independent tool for voice-based detection of Parkinson’s disease (PD) using graph neural networks (GNNs), demonstrating superior cross-linguistic generalization…
  • 2025 International Congress

    Evaluation Of Visual Perception Using Noise Pareidolia Test in Bangladeshi Patients with Parkinson’s disease.

    T. Zannat, E. Camboe, K. Dey, A. Zirra, A. Haque, D. Mair, S. Waters, C. Marshall, N. Mukadam, R. Weil, A. Noyce, A. Habib (Dhaka, Bangladesh)

    Objective: To evaluate the prevalence of visual misperception in patients with PD (PwP) in comparison with healthy control (HC) and its association with visual hallucinations.…
  • 2025 International Congress

    Ameliorating effect of linalool on anxiety disorders in Parkinson’s mice and related mechanisms

    F. Lou, M. Li (Shenyang, China)

    Objective: The aim of this study was to verify the ameliorating effect of linalool(LIN) on anxiety-related affective disorders and the associated receptors in a MPTP…
  • 2025 International Congress

    Caution in the creation of Parkinson’s disease cognitive composites

    D. Gonzalez, A. Karstens, J. Fleisher, S. Patel, C. Goetz (Chicago, USA)

    Objective: To evaluate the structural validity of new cognitive composites in Parkinson’s disease (PCCs). Background: PCCs created from constituent tasks are promising in their single-index…
  • « Previous Page
  • 1
  • …
  • 59
  • 60
  • 61
  • 62
  • 63
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley